![]() |
市场调查报告书
商品编码
1954634
全球医疗器材洩漏测试市场:市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析及预测(2026-2034 年)Medical Device Leak Testing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
全球医疗器材洩漏测试市场呈现强劲成长势头,主要受医疗器材产量不断增长以及产品安全和品质保证方面日益严格的监管要求的推动。根据 2025 年的报告,该市场在 2025 年的价值为 5.4182 亿美元,预计到 2026 年将成长至 5.9903 亿美元。到 2034 年,市场规模预计将达到 17.1482 亿美元,在预测期(2026-2034 年)内将维持 14.05% 的复合年增长率。 预计到2025年,亚太地区将以44.40%的市场占有率引领全球市场,这反映了该地区医疗器材製造基地的不断扩大。
市场概览
医疗器材洩漏测试是检测导管、血袋、植入式器械、呼吸器和其他关键器械洩漏的重要品质控管程序。洩漏检测可确保产品完整性、病患安全以及在商业化之前符合监管要求。根据器械类型和应用领域(例如心臟病学、泌尿外科、骨科和微创手术),会采用不同的测试方法。
随着全球慢性病发生率的上升,诊断和治疗程序激增,促使对医疗器材的需求增加。产量的成长直接促进了製造工厂对洩漏测试系统的采用。
新冠疫情的影响
新冠疫情对医疗器材洩漏测试市场产生了正面影响。 2020年,呼吸器、导管和其他重要医疗设备的需求显着成长。多家製造商扩大了产能以满足紧急医疗需求。例如,飞利浦在2020年将其呼吸器产能翻了一番。随着产量的增加,全球范围内进行的洩漏测试数量也显着增长。
儘管由于疫情高峰期的大规模采购,2021年洩漏测试数量略有下降,但对洩漏测试解决方案的总体需求依然强劲,支撑着市场的长期扩张。
市场趋势
影响市场发展的关键趋势之一是区域性洩漏测试服务提供者数量的增加。由于洩漏测试系统的安装和维护成本较高,许多中小型製造商选择将测试服务外包。 这种转变促使全球涌现新的服务提供者。
此外,製造商正在加速部署具有更高自动化和整合能力的先进洩漏测试仪,以满足不断变化的生产需求。
市场成长驱动因素
主要成长驱动因素是全球医疗器材产量的成长。 心血管、泌尿和骨科病例的增加正在加速对导管、植入式设备和手术器械的需求。
例如,英国约有 9 万人使用导管,全球数百万名患者依赖植入式心臟节律器。 製造设施的扩建,包括新建导管生产厂,进一步增加了对洩漏测试设备的需求。
此外,洩漏测试仪在製造现场的广泛应用(据估计全球已有数十万台)表明其渗透率很高,且采用率还在不断提高。
限制因子
儘管市场成长强劲,但由于洩漏测试仪成本高昂,市场仍面临挑战。先进的系统,例如氦气和氢气示踪气体测试设备,需要大量投资,这限制了中小製造商,特别是新兴经济体製造商的采用。 安装、校准和维护成本会进一步增加营运成本。
市场区隔分析
依测试类型
该市场依测试类型细分为压力衰减法、真空衰减法、示踪气体法和其他方法。
由于压力衰减法操作简单、易于自动化以及易于整合到装配线中,预计到2026年,其市场占有率将达到43.73%,位居榜首。真空衰减法和示踪气体法也因其在提高精度和符合法规要求方面的优势而日益普及。
依应用领域
应用领域包括心臟病学、泌尿科、骨科、微创/一般外科、糖尿病护理等。
预计到2026年,泌尿外科领域将占30.52%的市场占有率,这主要得益于导尿管使用量和泌尿外科手术量的增加。 随着心臟节律器和植入式医疗器材的日益普及,心臟病学领域也不断扩张。
依产品类型划分
市场区隔包括导管、血液相关器材、血袋、植入式医疗器材、大型设备等。
在产品频繁上市和全球高使用率的推动下,导管细分市场预计将在2026年占33.48%的市场占有率。 更严格的上市前洩漏验证监管要求进一步推动了该领域的成长。
亚太地区
亚太地区在2025年以2.4054亿美元的市场规模领跑,预计到2026年将达到2.6711亿美元。成长主要受医疗器材生产扩张、微创手术增多以及监管要求的推动。
北美
北美地区持续保持稳定成长,这得益于该地区心血管疾病和泌尿系统疾病的高发生率,以及众多领先的洩漏测试公司对先进技术的投资。
欧洲
在欧洲,人口老化和骨科手术的增加推动了对可靠洩漏测试解决方案的需求成长,预计该地区市场也将成长。
其他地区
其他地区由于监管意识的提高和医疗器材製造领域研发投入的增加,正经历着温和增长。
The global medical device leak testing market is witnessing robust growth, driven by the rising production of medical devices and stringent regulatory requirements for product safety and quality assurance. According to the 2025 report, the market was valued at USD 541.82 million in 2025 and is projected to grow to USD 599.03 million in 2026. By 2034, the market is expected to reach USD 1,714.82 million, registering a strong CAGR of 14.05% during the forecast period (2026-2034). In 2025, Asia Pacific dominated the global market with a 44.40% share, reflecting the region's expanding medical device manufacturing base.
Market Overview
Medical device leak testing is a mandatory quality control procedure used to detect leaks in devices such as catheters, blood bags, implantable devices, ventilators, and other critical equipment. Leak detection ensures product integrity, patient safety, and regulatory compliance before commercialization. Various testing methods are used depending on the device type and application area, including cardiology, urology, orthopedics, and minimally invasive surgery.
The increasing prevalence of chronic diseases worldwide has led to a surge in diagnostic and therapeutic procedures, which in turn has boosted the demand for medical devices. This expanding production volume directly contributes to higher adoption of leak testing systems across manufacturing facilities.
COVID-19 Impact
The COVID-19 pandemic had a positive impact on the medical device leak testing market. During 2020, the demand for ventilators, catheters, and other essential medical equipment surged significantly. Several manufacturers increased production capacity to meet urgent healthcare needs. For instance, Philips doubled its ventilator production capacity in 2020. The higher production volumes resulted in a substantial increase in the number of leak tests performed globally.
Although there was a slight decline in 2021 due to bulk procurement during the peak pandemic phase, overall demand for leak testing solutions remained strong, supporting long-term market expansion.
Market Trends
One of the key trends shaping the market is the growing number of regional leak testing service providers. Due to the high installation and maintenance costs of leak testing systems, many small and mid-sized manufacturers are outsourcing testing services. This shift has led to the emergence of new service providers globally.
Additionally, manufacturers are increasingly launching advanced leak testers with improved automation and integration capabilities to meet evolving production requirements.
Market Growth Drivers
The primary growth driver is the rising production of medical devices worldwide. Increasing cases of cardiovascular, urological, and orthopedic disorders are accelerating the demand for catheters, implantable devices, and surgical equipment.
For example, approximately 90,000 people use catheters in the U.K., and millions of patients globally rely on implantable pacemakers. Expanding manufacturing facilities, such as new catheter production plants, are further increasing the demand for leak testing equipment.
Moreover, the widespread installation of leak testers across manufacturing units-estimated in hundreds of thousands globally-demonstrates strong penetration and growing adoption.
Restraining Factors
Despite strong growth, the market faces challenges due to the high costs associated with leak testing equipment. Advanced systems such as helium and hydrogen-based tracer gas testers require significant investment, limiting adoption among small manufacturers, especially in emerging economies. Installation, calibration, and maintenance expenses further add to operational costs.
Market Segmentation Analysis
By Test Type
The market is segmented into pressure decay, vacuum decay, tracer gas, and others.
The pressure decay segment held the largest share of 43.73% in 2026, driven by its simplicity, automation compatibility, and easy integration into assembly lines. Vacuum decay and tracer gas testing methods are also gaining traction due to improved accuracy and regulatory compliance advantages.
By Application
Based on application, the market includes cardiology, urology, orthopedics, minimally invasive/general surgery, diabetes care, and others.
The urology segment accounted for 30.52% share in 2026, supported by rising catheter usage and urological procedures. Cardiology is also expanding due to growing adoption of pacemakers and implantable devices.
By Product Type
The market is segmented into catheters, blood devices, bags, implantable devices, capital equipment, and others.
The catheters segment dominated with a 33.48% share in 2026, owing to frequent product launches and high global usage rates. Increasing regulatory requirements for pre-market leak validation further strengthen segment growth.
Asia Pacific
Asia Pacific led the market in 2025 with USD 240.54 million, and the regional market reached USD 267.11 million in 2026. Growth is fueled by expanding medical device production, rising minimally invasive surgeries, and regulatory mandates.
North America
North America continues to grow steadily due to high prevalence of cardiovascular and urological disorders, along with strong presence of major leak testing companies launching advanced technologies.
Europe
Europe is witnessing growth driven by an aging population and increasing orthopedic procedures, boosting demand for reliable leak testing solutions.
Rest of the World
Other regions are experiencing gradual growth due to increasing regulatory awareness and growing R&D investments in medical device manufacturing.
Competitive Landscape
The market is semi-consolidated, with major players such as ATEQ Leaktesting, Cincinnati Test Systems, Pfeiffer Vacuum GmbH, InterTech Development Company, Uson L.P., Zaxis Inc., FasTest, and LACO Technologies. These companies are focusing on product innovation, partnerships, facility expansions, and geographic expansion to strengthen their market position.
Recent developments include facility expansions, product upgrades, and strategic collaborations aimed at enhancing leak detection capabilities and global outreach.
Conclusion
The global medical device leak testing market is positioned for substantial expansion, growing from USD 541.82 million in 2025 to USD 599.03 million in 2026, and projected to reach USD 1,714.82 million by 2034 at a CAGR of 14.05%. Rising medical device production, stringent regulatory standards, increasing chronic disease prevalence, and technological advancements in leak detection systems are the primary forces driving market growth worldwide.
Segmentation By Test Type
By Application
By Product Type
By Region